Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells
(Q32118812)
scientific article
scientific article
Language:
Current Data About
Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells
other details
description | scientific article |
External Links
(P356) |
10.1038/SJ.LEU.2402041
|
(P698) |
11237055
|
(P5875) |
12094966
|
(P6179) |
1047159890
|